263 related articles for article (PubMed ID: 28774835)
41. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
[TBL] [Abstract][Full Text] [Related]
43. Predictive biomarkers investigated in glioblastoma.
Tabouret E; Chinot O; Sanson M; Loundou A; Hoang-Xuan K; Delattre JY; Idbaih A
Expert Rev Mol Diagn; 2014 Sep; 14(7):883-93. PubMed ID: 25096963
[TBL] [Abstract][Full Text] [Related]
44. Quantification of MicroRNAs in Urine-Derived Specimens.
Fuessel S; Lohse-Fischer A; Vu Van D; Salomo K; Erdmann K; Wirth MP
Methods Mol Biol; 2018; 1655():201-226. PubMed ID: 28889388
[TBL] [Abstract][Full Text] [Related]
45. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
Ferracin M; Lupini L; Mangolini A; Negrini M
Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F
Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445
[TBL] [Abstract][Full Text] [Related]
47. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
48. Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling.
Soffietti R; Franchino F; Magistrello M; Pellerino A; Rudà R
Prog Neurol Surg; 2018; 31():168-179. PubMed ID: 29393185
[TBL] [Abstract][Full Text] [Related]
49. Pilocytic astrocytoma: a review of genetic and molecular factors, diagnostic and prognostic markers.
Bikowska-Opalach B; Szlufik S; Grajkowska W; Jozwiak J
Histol Histopathol; 2014 Oct; 29(10):1235-48. PubMed ID: 24554201
[TBL] [Abstract][Full Text] [Related]
50. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.
Baraniskin A; Zaslavska E; Nöpel-Dünnebacke S; Ahle G; Seidel S; Schlegel U; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2016 Mar; 18(3):361-7. PubMed ID: 26250566
[TBL] [Abstract][Full Text] [Related]
51. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
52. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
[TBL] [Abstract][Full Text] [Related]
53. Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.
Szajnik M; Czystowska-Kuźmicz M; Elishaev E; Whiteside TL
Expert Rev Mol Diagn; 2016 Aug; 16(8):811-26. PubMed ID: 27268121
[TBL] [Abstract][Full Text] [Related]
54. Cancer Stem Cell Biomarkers in the Nervous System.
Li X; Huang J; Kang Y; Cheng X; Yan Q; Zhang L; Fan J; Xu H
Front Biosci (Landmark Ed); 2023 Dec; 28(12):362. PubMed ID: 38179770
[TBL] [Abstract][Full Text] [Related]
55. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
Chandra Gupta S; Nandan Tripathi Y
Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
[TBL] [Abstract][Full Text] [Related]
56. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S; Saidijam M; Malih N
Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
59. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
Kumar D; Gupta D; Shankar S; Srivastava RK
Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
[TBL] [Abstract][Full Text] [Related]
60. Progress in the application of molecular biomarkers in gliomas.
Wang J; Su HK; Zhao HF; Chen ZP; To SS
Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
